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Abstract
Introduction: Postpartum constipation is a common problem women face after delivery.
Vaginal tears, pain medications, hormonal changes, decreased activity, dietary changes,
and hemorrhoids can all increase the risk of developing constipation in the postpartum
period. Evidence Summary: Constipation can cause pain, discomfort, decreased quality
of life, and life-long consequences if left untreated. Nurses have a responsibility to the
patient to provide quality care by taking a proactive approach to bowel management.
Regular assessment of patient bowel habits and the provision of education on nonpharmacologic and pharmacologic prevention measures are recommended. Gaps: There
is a lack of literature specific to constipation in the postpartum population, and the
literature lacks specific guidelines for management due to the subjective nature of the
problem. Recommendations for Practice: Prevention of constipation is superior to
treating the problem after it has already occurred. Discussing prevention interventions
with patients on admission and daily thereafter can improve quality of care and
potentially reduce constipation related pain and discomfort.
Keywords: postpartum constipation prevention, PRN laxatives
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Early Education and Laxative Utilization in Postpartum Constipation Prevention
Postpartum constipation is a common problem women face after delivery with a
prevalence rate of about 41.8% (Cooklin, Amir, Jarman, Cullinane, & Donath, 2015;
Turawa, Musekiwa, & Rohwer, 2015). Constipation can be characterized by hard or
lumpy stools, stools that are difficult to pass, and the feeling of incomplete evacuation
(Turawa et al., 2015). Vaginal tears, pain medications, hormonal changes, decreased
activity, dietary changes, and hemorrhoids are common in the postpartum period and put
a new mother at increased risk for constipation (Cerny, 2015). Constipation in the
postpartum period increases the patient’s pain and discomfort and decreases overall
quality of life (Turawa et al., 2015). Prevention of postpartum constipation is superior to
treating the problem after it has already occurred, because prevention is easier and less
expensive than treatment (Lamb & Sanders, 2015). Educating patients about lifestyle and
medication options is important for prevention of postpartum constipation (WesselCessieux, 2015).
A literature search of all English-language studies on postpartum constipation was
performed. CINAHL, EBSCOhost, Medline, Pubmed, and Google Scholar were
searched using the keywords: prevention, postpartum, laxative, and pain combined with
the keyword constipation. Exclusion criteria included studies focused on prevention and
treatment of pediatric constipation and chronic constipation as there are differences in
treatment approaches with those populations. Evidence that involved prevention and
treatment of acute constipation in all adult populations was included, because there were
a limited number of articles involving only the postpartum population. Additional
inclusion criteria included studies published within the last five years, full-text, and in the
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English language. The Johns Hopkins Nursing Evidence Level and Quality Guide was
utilized for evidence appraisal. See Appendix B for a description of each evidence and
quality level. There were 1-IB, 1-IIA, 1-IIB, 1-IIIA, 1-IIIB, 4-IVA, 1-IVB, and 3-VA
quality pieces of evidence. See Appendix A for the evidence table. The review of
literature was guided by the clinical question: In post-delivery patients on a postpartum
unit (P), does the provision of structured education about laxatives, diet, and exercise for
constipation prevention (I) compared to the current practice of inconsistent constipation
prevention education (C) influence the administration of PRN laxative medications
during hospitalization (O) within a 90 day time-frame (T)?
Evidence Summary
Women are at an increased risk of developing constipation, especially in the
postpartum period. Postpartum patients may fear the pain of having a bowel movement if
hemorrhoids or vaginal lacerations are present, which contributes to constipation.
Constipation is largely subjective causing the exact burden to be not well known. The
postpartum period is a time of hormonal, physical, and emotional stress on the body, and
constipation can place additional stress on a new mother and decrease quality of life
(Turawa et al., 2015).
Constipation susceptibility increases with age and pregnancy, and women have a
higher prevalence than men (Forootan, Bagherl, & Darvishl, 2018). Constipation is often
caused by slow colonic transit, a low fiber diet, a sedentary lifestyle, and frequently
ignoring the urge to defecate. It is generally characterized by hard stool that is difficult to
pass, infrequent bowel movements, straining to pass stool, and the feeling of incomplete
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bowel evacuation (Lee, 2015). However, the definition is largely based on personal
perception and can be misleading and debated (Lamb & Sanders, 2015).
Risk of constipation in the postpartum. There are a number of factors that put
mothers at an increased risk for the development of constipation during the postpartum
period. Vaginal tears, pain medications, hormonal changes, decreased activity, dietary
changes, and hemorrhoids can all increase the risk of developing constipation. Vaginal
tears can cause perineum tenderness and create anxiety and hesitancy for the patient’s
first bowel movement. Opioid pain and labor medications decrease gut motility leading
to constipating effects (Cerny, 2015). Acknowledging risk factors and discussing
prevention interventions with patients can improve quality of care and decrease the
likelihood of constipation related complications (Lee, 2015).
Consequences. Constipation can be an embarrassing topic for many women to
bring forth to their care provider. They may feel that constipation is normal after
pregnancy. Pain and discomfort caused by constipation in the postpartum period can
place additional stress on a new mother that is recuperating from the effects of delivery
(Turawa et al., 2015). Left untreated, constipation can worsen and potentially cause
lifelong complications like hemorrhoids, anal fissures, and rectal prolapse. Hemorrhoids
are caused by straining and passing hard stool and can cause itching, burning, pain, and
sometimes bleeding with defecation (Lamb & Sanders, 2015). Straining can also damage
the pudendal nerve and weaken the muscles of the pelvic floor (Verghese et al., 2015).
Non-pharmacologic. Non-pharmacological management of constipation is often
underutilized in the hospital setting due in large part to the readily available medication
options (Wessel-Cessieux, 2015). Healthy lifestyle factors can play an important role in
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the prevention of constipation (Lamb & Sanders, 2015). A low-fiber diet, low fluidintake, and physical inactivity are risk factors for the development of constipation.
Eating a diet high in fiber (whole grains, rice, fresh fruits and vegetables, beans, nuts, and
dried fruit), increasing water intake to a minimum of 2 liters per day, and getting up and
walking early in the postpartum period are recommended to prevent constipation. Foods
high in fiber should be introduced gradually to a goal of 25-30 grams of fiber per day.
Bloating and flatulence are potential side-effects of introducing too much fiber too
quickly in the diet (Shin, Toto, & Schey, 2015). Adequate hydration is important because
it helps move gastric content through the digestive tract. Fiber makes food softer and
bulkier, which eases stool passage (Forootan et al., 2018).
Pharmacologics. For some people, medications may be required to prevent or
relieve constipation (Bardsley, 2017). Laxatives are the drug of choice if
pharmacological intervention is necessary (Turawa et al., 2015). Laxatives can help
prevent and relieve constipation by various mechanisms of action depending on the drug.
Bulk-forming laxatives work by bulking up stool through water absorption and
prompting intestinal contraction. Osmotic laxatives work by drawing water into the
colon to ease stool transit. Stimulant laxatives work by stimulating intestinal contraction
(Forootan et al., 2018). Stool softeners are another option if fluid and fiber intake is
adequate. There is limited evidence to support use as monotherapy. In women with
vaginal tears, the recommendation is to use a stool softener and an osmotic laxative for
around 10 days after delivery (Shin et al., 2015).
Medications used for constipation relief should always be taken with caution
during pregnancy and while breastfeeding. Women may use medication they had prior to
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pregnancy or seek advice from family and friends about what medications they should
take for constipation. Proper education from care providers is essential to promote safe
and effective medication options for the postpartum breastfeeding mother (Lamb &
Sanders, 2015).
A laxative that is not excreted in breast milk and is effective and well tolerated
should be chosen (Verghese, Futaba, & Latthe, 2015). Bulk, osmotic, and stimulant
laxatives and stool softeners are all safe to use while breastfeeding. Osmotic and bulk
laxatives are the preferred first-line choice of laxatives. However, bulk laxatives can take
up to 72 hours to take full effect and should not be used for opioid-induced constipation.
Stimulant laxatives can be used occasionally for a rapid-acting effect when colon motility
is poor, as in the case of opioid-induced constipation. Stool softeners are best used in
combination with other laxatives (United States National Library of Medicine, 2019).
When feces remain in the bowel for an extended time, more water is reabsorbed
and stool becomes harder and more difficult to pass (Bardsley, 2017). Osmotic laxatives
like polyethylene glycol and magnesium citrate work by keeping fluid in the bowel and
are good options for constipation prevention and treatment. Stimulant laxatives work by
increasing intestinal motility and are more effective than bulk-forming laxatives in
pregnancy (Lamb & Sanders, 2015).
Nurses role. Nurses play a key role in recognizing, preventing, and treating
constipation (Lee, 2015). Research shows that the management of constipation by
providers is often performed inadequately. A lack of knowledge of the assessment and
management of constipation can lead to poorer outcomes. Nurses are often educated to
monitor and intervene after the complaint is already evident rather than assessing bowel
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habits prior to a problem. A proper bowel assessment includes the identification of the
patient’s typical bowel pattern, last bowel movement, diet, mobility, fluid intake,
medications, previous bowel complications, and present concerns (Shin et al., 2015).
The medications used for constipation are often scheduled PRN to enable
individualized treatment based on patient’s needs. PRN medications place a great deal of
responsibility on the nurse to offer the medications and educate on available options
(Shin et al., 2015). Nurses need to assess bowel management and constipation on
admission and daily thereafter to provide optimal care and health promotion (Zanik &
Gray, 2015). Currently, there is no clinical practice guideline to govern exact timing for
education provision.
Gaps in the Literature

Constipation does not have a universally accepted definition due to its
subjectivity, which can make it difficult to determine when a person’s normal bowel
pattern is adversely effected (Lee, 2015). The lack of a clear definition makes outcomes
of constipation interventions difficult to measure, which may be the reason for the lack of
quality research studies regarding postpartum constipation prevention measures.
Constipation is the most common bowel problem in older adults and patients
taking opioid pain medications, so many of the studies found within the search focused
on constipation in those populations (Wessel-Cessieux, 2015). There were very few that
focused on the postpartum population independently. With scarce research specific to
postpartum constipation prevention, there was limited evidence on many of the
pharmacologic and non-pharmacologic interventions used to treat constipation.
There are no studies that offer specific guidance on a bowel management regimen
for postpartum mothers in the hospital setting. Dietary changes and increased fluid intake
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are currently recommended as non-pharmacological options of preventing constipation,
but the evidence is largely based on expert opinion, rather than clinical trials (Bardsley,
2017). There was also insufficient research to offer guidance on the order for which
pharmacological interventions should be utilized in the postpartum period (Sanders &
Lamb, 2015).
Recommendations for Practice
Research suggests a proactive approach to bowel management to prevent
complications of constipation (Zanik & Gray, 2015). Prevention of constipation is
superior to treating the problem after it has already occurred (Lamb & Sanders, 2015).
Nurses are in a position to identify patients who are at risk for constipation on admission
and educate them about both pharmacologic and non-pharmacologic measures early in
their hospital stay. A proper patient bowel history is important to identify the patient’s
typical bowel routine, date of last bowel movement, medications that may contribute to
constipation, and any previous bowel complications (Shin et al., 2015). Increased intake
of fluids, exercise, and consumption of foods high in fiber along with the use of osmotic,
bulk, and stimulant laxatives for women at increased risk may be effective in the
prevention and management of constipation in the immediate postpartum period (WesselCessieux, 2015).
Conclusion
Postpartum constipation is a preventable complication with proper education early
in the patient’s stay. Prevention is superior to treating the problem once it has already
occurred. The provision of structured education about laxatives, diet, and exercise from
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the bedside nurse has the potential to increase the utilization of PRN laxative medications
and decrease prevalence of constipation in the postpartum period.
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Appendix A
Evidence Table
Author,
Year

Study
Objective/
Intervention
Or exposures
compared

Design

Sample (N)

Outcomes
Studied
(how
Measured)

Results

Quality

Graziano
et al., 2014

Assessment of
bowel
function in the
peripartum
period

Randomized
Control Trial

101
participants

2/3 of women
had normal
stool transit
times
postpartum.
Breastfeeding
and cesarean
delivery
increase stool
transit times.

1B

Zanik &
Gray, 2015

Assessed preand postaudit of
CRAT
utilization

QuasiExperimental
Study

50
inpatients

Patients
received a
survey to
record date
and
consistency
of 1st bowel
movement.
Bristol Stool
Form Scale
was used.
Documentati

2A

Turawa,
Musekiwa,
& Rohwer,
2015

Quality of
evidence to
support
various
interventions
that prevent
postpartum
constipation
Treating and
managing
constipation

Systematic
Review with
RCTs and
quasirandomized
trials

5 trials

Documentati
on of bowel
on of bowel
movements
activity
increased
from 8% to
75% after
implementing
CRAT
4 compared
Insufficient
a laxative vs. evidence to
placebo and
conclude
1 compared effectiveness
laxative plus and safety of
bulking
laxatives
agent

Systematic
Review and
MetaAnalysis:
NonExperimental

80 Articles

Diagnosis
and
management
of
constipation

3A

Forootan,
Bagherl, &
Darvishl,
2018

Diagnostic
and
therapeutic
options
important

2B
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Cooklin,
To study
Non229
Amir,
maternal
Experimental primiparous
Jarman,
physical
study
women
Cullinane,
health
& Donath, symptoms in
2015
the 8 weeks
postpartum

Bardsley,
2017

Assessment
and treatment
options for
patients with
constipation

Research
article

N/A

A checklist
of
postpartum
health
symptoms
and
assessment
of fatigue
symptoms
N/A

Women have
significant
health issues
in the first
weeks of the
postpartum
period

3B

N/A

4A

Shin, Toto,
& Schey,
2015

Postpartum
bowel
changes

Consensus
Panels

N/A

N/A

N/A

4A

Verghese,
Futaba, &
Latthe,
2015

Constipation
in pregnancy

Expert
opinion

N/A

N/A

N/A

4A

WesselCessieux,
2015

Constipation
management
in older
people in
hospital

Double-blind
peer
reviewed
article

N/A

N/A

N/A

4A

Cerny,
2015

Interventions
to prevent and
treat
postpartum
constipation

Expert
opinion

N/A

N/A

N/A

4B

Emly &
Marriott,
2017

Management
of
Constipation

Research
Article

N/A

N/A

N/A

5A
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Lamb &
Education and
Research
N/A
Sanders,
interventions
Article
2015
for
constipation
and
hemorrhoids
Lee, 2015
Combating
Double-blind
N/A
Constipation
Peer Review
Research
Article

N/A

N/A

5A

N/A

N/A

5A
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Appendix B
Johns Hopkins Nursing Evidence-Based Practice Appraisal Tool

Evidence Levels

Level I
Experimental study, randomized controlled trial
(RCT)
Explanatory mixed method design that includes
only a level I quantitative study
Systematic review of RCTs, with or without metaanalysis

Level II
Quasi-experimental study
Explanatory mixed method design that includes
only a level II quaNtitative study
Systematic review of a combination of RCTs and
quasi-experimental studies, or quasi-experimental
studies only, with or without meta-analysis

Level III

Nonexperimental study
Systematic review of a combination of RCTs,
quasi-experimental and nonexperimental studies,
or nonexperimental studies only, with or without
meta-analysis
Exploratory, convergent, or multiphasic mixed
methods studies
Explanatory mixed method design that includes
only a level III quaNtitative study
QuaLitative study Meta-synthesis

Quality Ratings

Quantitative Studies
A High quality: Consistent, generalizable results;
sufficient sample size for the study design; adequate
control; definitive conclusions; consistent
recommendations based on comprehensive literature
review that includes thorough reference to scientific
evidence.
B Good quality: Reasonably consistent results;
sufficient sample size for the study design; some
control, fairly definitive conclusions; reasonably
consistent recommendations based on fairly
comprehensive literature review that includes some
reference to scientific evidence.
C Low quality or major flaws: Little evidence with
inconsistent results; insufficient sample size for the
study design; conclusions cannot be drawn.

Qualitative Studies
No commonly agreed-on principles exist for judging the
quality of quaLitative studies. It is a subjective process
based on the extent to which study data contributes to
synthesis and how much information is known about the
researchers’ efforts to meet the appraisal criteria.
For meta-synthesis, there is preliminary agreement that
quality assessments of individual studies should be
made before synthesis to screen out poor-quality
studies1.
A/B High/Good quality is used for single studies and
meta-syntheses2.
The report discusses efforts to enhance or evaluate
the quality of the data and the overall inquiry in
sufficient detail; and it describes the specific
techniques used to enhance the quality of the
inquiry. Evidence of some or all of the following is
found in the report:
• Transparency: Describes how information
was documented to justify decisions, how
data were reviewed by others, and how
themes and categories were formulated.
• Diligence: Reads and rereads data to check
interpretations; seeks opportunity to find
multiple sources to corroborate evidence.
• Verification: The process of checking,
confirming, and ensuring methodologic
coherence.
• Self-reflection and scrutiny: Being
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continuously aware of how a researcher’s
experiences, background, or prejudices might
shape and bias analysis and interpretations.
• Participant-driven inquiry: Participants shape
the scope and breadth of questions; analysis
and interpretation give voice to those who
participated.
• Insightful interpretation: Data and knowledge
are linked in meaningful ways to relevant
literature.
C Low quality studies contribute little to the overall
review of findings and have few, if any, of the
features listed for high/good quality.

Evidence Levels

Quality Ratings

Level IV

A High quality: Material officially sponsored by a professional,

Opinion of respected authorities
and/or nationally recognized
expert committees or consensus
panels based on scientific
evidence
Includes:

public, or private organization or a government agency;
documentation of a systematic literature search strategy;
consistent results with sufficient numbers of well-designed
studies; criteria-based evaluation of overall scientific strength
and quality of included studies and definitive conclusions;
national expertise clearly evident; developed or revised within
the past five years

• Clinical practice

B Good quality: Material officially sponsored by a professional,

guidelines

public, or private organization or a government agency;
reasonably thorough and appropriate systematic literature search
strategy; reasonably consistent results, sufficient numbers of
well-designed studies; evaluation of strengths and limitations of
included studies with fairly definitive conclusions; national
expertise clearly evident; developed or revised within the past
five years

• Consensus panels/position
statements

C Low quality or major flaws: Material not sponsored by an
official organization or agency; undefined, poorly defined, or
limited literature search strategy; no evaluation of strengths and
limitations of included studies, insufficient evidence with
inconsistent results, conclusions cannot be drawn; not revised
within the past five years

Level V
Based on experiential and
nonresearch evidence
Includes:
• Integrative reviews
• Literature reviews
• Quality improvement,
program, or financial
evaluation

• Case reports
• Opinion of nationally
recognized expert(s) based on
experiential evidence

Organizational Experience (quality
improvement, program or financial evaluation)

A High quality: Clear aims and objectives; consistent results
across multiple settings; formal quality improvement, financial,
or program evaluation methods used; definitive conclusions;
consistent recommendations with thorough reference to scientific
evidence
B Good quality: Clear aims and objectives; consistent results in
a single setting; formal quality improvement, financial, or
program evaluation methods used; reasonably consistent
recommendations with some reference to scientific evidence

C Low quality or major flaws: Unclear or missing aims and
objectives; inconsistent results; poorly defined quality
improvement, financial, or program evaluation methods;
recommendations cannot be made

Integrative Review, Literature Review, Expert
Opinion, Case Report, Community Standard,
Clinician Experience, Consumer Preference

A High quality: Expertise is clearly evident; draws definitive
conclusions; provides scientific rationale; thought leader(s) in the
field
B Good quality: Expertise appears to be credible; draws fairly
definitive conclusions; provides logical argument for opinions
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C Low quality or major flaws: Expertise is not discernable or
is dubious; conclusions cannot be drawn
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Abstract
Background/Purpose: Women in the postpartum period are at increased risk for
the development of constipation, which can cause additional discomfort and
decrease overall quality of life. Increasing dietary fiber and water intake, early
ambulation, and laxatives as needed are recommended for prevention and
treatment of constipation. Methods: A DNP Project was implemented on a
postpartum unit to determine if the provision of prevention education and offering
of PRN laxative medications by nurses upon arrival to the postpartum unit
influenced the number of PRN laxative medications administered. Conclusions:
The Project spanned 3 months. Data was collected from the EMR regarding
administration of PRN laxative medications and education the patients received
on constipation prevention upon admission to the postpartum unit. The identical
type of data was collected on qualifying patients from the same three-months
from the year prior. Statistical significance was found for an increase in PRN
laxative administration post-intervention. Implications for Practice: Upon
comparison of the data, it was found that early patient education and offering of
pharmacological therapy from the nursing staff early in the hospital stay increased
the administration of PRN laxative medications which could lead to decreased
constipation in the postpartum period.
Keywords: postpartum constipation prevention, PRN laxatives
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The Effects of Early Laxative, Diet, and Exercise Education on Postpartum
Constipation Prevention
Postpartum constipation is a common problem women face after delivery due to
an increase in risk factors such as vaginal tears, pain medications, hormonal changes,
decreased activity, dietary changes, and hemorrhoids (Cooklin, Amir, Jarman, Cullinane,
& Donath, 2015; Cerny, 2015). Prevention is superior to treating the problem after it has
already occurred and early awareness of the causes and treatments of postpartum
constipation can help with prevention (Lamb & Sanders, 2015). Educating patients about
lifestyle modifications and medication options to combat constipation are important
prevention strategies (Wessel-Cessieux, 2015).
Significance. Postpartum constipation can negatively impact the quality of life
and cause additional discomfort for a new mother who is adjusting to bodily stressors
caused by delivery (Turawa, Musekiwa, & Rohwer 2015). Constipation can impact a
mother’s physical and social health and hinder the ability to care for her newborn’s needs
due to abdominal discomfort and complications such as hemorrhoids (Lamb & Sanders,
2015). Early awareness of the causes and treatments of postpartum constipation can help
with prevention.
Nurses in the hospital setting are in a position to recognize patients at risk for
constipation and provide education about good bowel habits early in their stay (WesselCessieux, 2015). Prior to the DNP Project’s implementation, there was no structured
educational intervention on the postpartum unit where the project took place. Patients
were provided printed material with constipation prevention education in their discharge
paperwork but were not given any formal education early in the stay. Nurses dispensed
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laxatives in a reactive manner, rather than offering them to patients early in their stay (A.
Christensen, personal communication, June 25, 2018).
Decreased quality of life and additional stress and discomfort with defecation are
possible complications of delayed prevention/treatment. The process of delivering a
baby, either cesarean section or vaginally, places a great deal of stress on the body, and
additional pain and discomfort related to defecation can exacerbate stress on the new
mother. Pressure on the rectal wall leads to pain and restlessness in the patient and
decreases quality of life (Turawa et al., 2015).
PICOT question. The Doctor of Nursing Practice (DNP) Project was guided by
the clinical question, which utilizes the PICOT framework. The PICOT question was: In
post-delivery patients on a postpartum unit (P), does the provision of structured education
about laxatives, diet, and exercise for constipation prevention (I) compared to the current
practice of inconsistent constipation prevention education (C) influence the
administration of PRN laxative medications during hospitalization (O) within a 90 day
time-frame (T)?
Synthesis of the Evidence
Health professionals may fail to effectively assess and treat constipation in the
immediate postpartum period due to the sensitivity of the topic for some patients. A
proactive approach needs to taken and patients should be given education and advice
about what laxatives are available to them, diet, and safe amount of exercise for bowel
management within an hour of admission to the postpartum unit. Non-pharmacological
management of constipation is often underutilized in the hospital setting due in large part
to the readily available medication options (Wessel-Cessieux, 2015).

3
POSTPARTUM CONSTIPATION PREVENTION
Nurses are often educated to monitor and intervene after the complaint is already
evident rather than assessing bowel habits prior to a problem. Nurses need to assess
bowel management and risk for constipation on admission to the postpartum unit and
daily thereafter to provide optimal care and health promotion (Zanik & Gray, 2015). Pain
and discomfort can develop if constipation develops and can place additional stress on a
new mother that is recuperating from the effects of delivery (Turawa et al., 2015). Left
untreated, constipation can worsen and potentially cause lifelong complications like
hemorrhoids, anal fissures, and rectal prolapse (Lamb & Sanders, 2015).
Gaps in the Literature
Constipation is a subjective condition without a universally accepted definition,
which makes it difficult to agree on the exact prevalence of constipation. There is also
very little literature on assessment tools and risk factors of constipation in the acute
hospital setting (Wessel-Cessieux, 2015). General conclusions cannot be drawn about
the safety and effectiveness of laxative use for inpatient postpartum patients based on
current literature (Turawa et al., 2015).
Recommendations for Practice
Research suggests a proactive approach to bowel management to prevent
complications of constipation (Zanik & Gray, 2015). Nurses should identify patients who
are at risk for constipation on admission and educate them about both pharmacologic and
non-pharmacologic measures (Wessel-Cessieux, 2015). The education provided should
include increasing daily water intake to a minimum of 2 liters per day, consume a diet
high in fiber (25-30g) per day, fruits, and vegetables, ambulating as much as condition
allows, and utilizing laxatives as needed per physician order. Osmotic and bulk laxatives
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are the preferred first-line choice. However, bulk laxatives can take up to 72 hours to take
full effect. Stimulant laxatives can be used occasionally for a rapid-acting effect (United
States National Library of Medicine, 2019).
Methods
Setting. The DNP Project took place on an urban Midwestern hospital’s 24-bed
postpartum unit. The unit’s population includes postpartum women who have delivered
vaginally or through cesarean section (c-section), newborn babies, and postoperative
breast/gynecological procedure patients. The unit typically staffs between two and eight
Registered Nurses (RNs). The nurses typically work 12 hour shifts and are assigned four
to five patients each (A. Christensen, personal communication, June 25, 2018).
Sample. The sample population consisted of post-delivery patients. Women
aged 18 and older who delivered via cesarean section or vaginally were included in the
project. Three hundred seventy-one (71%) of the pre-intervention and 363 (73%) of the
post-intervention sample population delivered vaginally. One hundred fifty-three (29%)
of the pre-intervention and 135 (27%) of the post-intervention sample population
delivered via c-section. The age range of women included in the project was between the
ages of 18 and 47 years of age. See Appendix F. The typical length of stay ranged from
24-72 hours. The majority of the patient population was White/Caucasian, but the unit
also serves a large number of Hispanic and Nepali women. An audio-visual interpreter
service was utilized to educate non-English speaking persons (A. Christensen, personal
communication, June 25, 2018).
Development of the intervention tool. Prior to the DNP Project implementation,
patients on the postpartum unit received a welcome packet with information about the
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unit and the early postpartum period, which did not include information on prevention of
constipation. Evidence-based information on lifestyle modifications and medication
options for the prevention of postpartum constipation was added to the existing welcome
packet and was addressed by the bedside nurse within an hour of patient admission to the
postpartum unit. The Project Coordinator created this educational insert based on
evidence-based constipation prevention literature. See Appendix C. A time stamp in the
electronic medical record (EMR) was created by the facility information technology
department to document that the education was provided.
The Project Coordinator created an evidence-based educational power point and
presented the information on the new process to the nurses at a mandatory unit meeting.
The power point included a detailed explanation of the nurse’s role in the DNP Project
and drug information about each class of laxative medication. The presentation was
included in the weekly update email for nurses that were unable to attend the unit
meeting. Questions were encouraged and answered. See Appendix D.
Project procedure. The DNP Project was guided by Lewin’s Change Model,
Imogene King’s Theory of Goal Attainment, and the Johns Hopkins Nursing EvidenceBased Practice Model (Lewin, 1952; King, 1981; Johns Hopkins Medicine, n.d.). The
DNP Project coordinator attended a unit meeting and discussed the nurse’s role in the
project and gained feedback from the staff and management. A presentation was given to
educate the nurses on pharmacologic and non-pharmacologic constipation prevention
measures available to patients upon admission to the postpartum unit. Information about
the project was also given in the nursing daily line-up and weekly update to ensure that
all staff received the proper education on implementing the project.
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Project implementation spanned three-months. During that time, nurses provided
written and verbal constipation prevention education to patients and offered laxative
therapy within one hour of admission to the unit. Teach-back was utilized to ensure
patient understanding. After providing the education, nurses documented completion of
the task via a time-stamp intervention in the EMR. After providing the initial education,
the nurses addressed constipation prevention and offered pharmacologic therapy at least
once per 12 hour shift.
At the end of the three months, data was collected from the EMR regarding
administration of PRN laxative medications. The same type of data was collected on
qualifying patients from the same three-months from the year prior. The two were
compared to establish whether early patient education and offering of laxatives from the
nursing staff early in the hospital stay had an effect on the administration of PRN laxative
medications.
Ethical considerations. Approval from the hospital’s Nursing Research
Committee and IRB and the university’s Human Subjects Committee was obtained prior
to the start of the DNP Project. See Appendix A & B. The research data contains no
patient identifiers and will be kept on a password protected computer at the project
coordinator’s home residence for a minimum of six years.
Conclusions
Clinical outcomes. The independent samples t-test was utilized for data analysis.
Statistical difference was found when comparing pre-intervention laxative administration
and post-intervention laxative administration. Pre-intervention mean laxative
administration was 1.17 doses per patient (n = 524). Post-intervention, mean laxative
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administration was 1.37 doses per patient (n = 498). The independent samples t-test was
p=<0.021. Statistical significance (p<0.05) was achieved for an increase in PRN laxative
administration in the post-intervention sample. See Appendix H. Three hundred-thirteen
patients (60%) received at least one dose of a PRN laxative. Two hundred-eleven patients
(40%) received no PRN laxative medications and of those, seven patients (1%) had no
PRN laxative medications ordered. Three hundred twenty-three patients (65%) received
at least one dose of a PRN laxative. One hundred seventy-five patients (35%) received no
PRN laxative medications and of those, 20 patients (4%) had no PRN laxative
medications ordered. See Appendix G for specific data numbers per type of medication.
Feedback via a Likert-scale questionnaire sent out via email using the Survey
Monkey Program was obtained from the nurses after project completion to gain
knowledge of success and challenges. Nine of 40 staff members (22%) participated in
the survey. See Appendix E for survey results and comments.
Implications for Practice
Early patient education and offering of pharmacological therapy from the nursing
staff early in the hospital stay showed a statistically significant increase in the
administration of PRN laxative medication. The provision of structured education to the
nursing staff about constipation prevention led to an increase in patient education and
laxative utilization. By offering laxative medications earlier and more consistently in the
hospital stay, there is a better chance of reducing postpartum constipation and the
associated discomfort. All staff who offered feedback on the DNP Project felt they were
better equipped to prevent postpartum constipation in their patients by providing
structured education and consistently offering PRN laxatives.
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Barriers/Limitations. The Project relied heavily on nurse implementation. Nurse
buy-in was important to ensuring they were motivated to provide the education in a
timely manner. The hospital-stay of postpartum patients is relatively short, so finding a
measurable outcome that captured the influence of inpatient constipation prevention was
difficult. Many women may not have a bowel movement before discharge in relation to
the short length of stay. Discovering the influence of scheduled laxative medications on
constipation prevention was originally discussed, but changing order-sets was not an
option. There are no standing orders for PRN laxative medications, so the nurse is unable
to administer the medications if the provider does not place the orders.
Sustainability/Future Projects. Getting management interested in the project
early in the process was important for sustainability. Presenting the project findings at a
unit meeting and gaining staff feedback about the benefits and challenges also helped
with permanent implementation of the change. The constipation prevention education
continues to be printed in the welcome packet for all patients leading to sustainability of
the project. The addition of standard order sets for laxatives in postpartum patients
would ensure that PRN medications are always readily available to the patients. A future
project that identifies efficacy of a risk factor identification algorithm and subsequent
stepped laxative treatment plan would also be beneficial.
Postpartum constipation is a preventable complication with proper education early
in the patient’s stay. Prevention of constipation is superior to treatment. The provision
of structured education about laxatives, diet, and exercise from the nursing staff increased
utilization of PRN laxative medications and may have decreased the prevalence of
constipation in the postpartum period.
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Appendix C
Welcome Packet Education
Constipation Prevention
Walk in the hallways as tolerated
Increase water intake to at least 2 liters per day
Increase fiber to (25-30g) per day with intake of fresh fruits and vegetables, whole grains,
bran, nuts, beans, and rice
Ask your nurse about available medications to assist with bowel movement
(Shin, Toto, & Shey, 2015)
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Appendix D
Staff Nurse Education
Slide 1

Slide 2
41.8 % of postpartum women report
constipation
 Increased risk of constipation related to:



›
›
›
›

Hormones
Vaginal tears
Hemorrhoids
Pain meds

(Turawa, Musekiwa, & Rohwer, 2015; Verghes, Futaba, & Latthe,
2015)
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Slide 3


Impact
→Decreased quality of life
→pain & discomfort
→hinder ability to care for newborn



Prevention
› Early awareness
› Non-pharmacologics
› Laxatives
(Turawa et al., 2015;Wessel-Cessieux, 2015)

Slide 4
Sensitive subject to approach→ leads to
ineffective assessment and treatment
 Proactive approach is best
 Non-pharmacologic
 Pharmacologic
 Proper management plan can prevent
and treat



(Wessel-Cessieux, 2015)

Slide 5
Proper management plan
Identify those at risk
 Educate about non-pharmacologics





› Fluid intake

› Exercise
› High-fiber



Educate about pharmacologics
› Osmotic, bulk, and stimulant laxatives
(Wessel-Cessieux, 2015)
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Slide 6
 Distribution

of education in
welcome packet within 1 hour of
admission to postpartum unit
 Address PRN medication options
at least once per shift
 Time-stamp intervention in EMR (I
did it)- Will pink up with admission
order set

Slide 7
Constipation Prevention
 Walk in the hallways as tolerated
 Increase water intake to at least 2 liters
per day (about 3 ½ water pitchers)
 Increase fiber to (25-30g) per day with
intake of fresh fruits and vegetables,
whole grains, bran, nuts, beans, and rice
 Ask your nurse about available
medications to assist with bowel
movement
(Shin, Toto, & Shey, 2015)

Slide 8







Not for acute constipation- takes several
days to work
Not for use of opioid-induced constipation
Onset of Action- 48-72 hours
Need adequate fluid intake
Start slow- can cause abdominal discomfort
Examples: Metamucil and Fybogel

(Shin et al., 2015)
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Slide 9
Need adequate fluid and fiber
consumption
 Works by drawing water into the colon
for easier stool transit
 Example: polyethylene glycol (Miralax)
 Onset of Action: 24-72 hours



(Shin et al., 2015)

Slide 10
Need adequate fluid and fiber
Limited efficacy as monotherapy
 Not to be used long term
 Contraindications: inflammatory bowel &
bowel obstruction
 Example: docusate sodium (Colace)
 Onset of Action: 24-72 hours





(Shin et al., 2015)

Slide 11
Typically used as last-line and opioidinduced constipation
 Ensure adequate fiber and fluids
 Abuse may lead to difficulties with bowel
movements when medication stopped
 Examples: Senokot, Senna, Bisalax, and
Dulcolax rectal suppository
 Onset of Action: 6-12 hours, 5-60 minutes
for Dulcolax



(Shin et al., 2015)
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Slide 12

Thank You!!

Slide 13
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Appendix E
Nurse Feedback Questionnaire
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